Bryce Baird

Dr. Bryce Baird

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Translational Andrology and Urology
Verified
Journal Article
Open access
PDF file
BBBryce Baird
Bryce Baird
KPKevin Parikh
Kevin Parikh
GBGregory Broderick
Gregory Broderick
Penile implant infection factors: a contemporary narrative review of literature Bryce A. Baird, Kevin Parikh, Gregory Broderick

22 October 2021 in Sexual Medicine
Verified
Journal Article
Open access
BBBryce Baird
Bryce Baird
NRNick Robertson
Nick Robertson
AGA Broderick Gregory
A Broderick Gregory
Introduction: Penile enhancement procedures are becoming more common in men looking to achieve a more desirable penile aesthetic. We describe a case of post-procedural dermatitis after receiving penile girth enhancement injections in an adult male and discuss management of penile girth injection side effects. Materials and Methods: We review and present our case alongside a discussion of girth injection complications. Results: Patient's exam and symptoms improved after treatment. Conclusion: Post-procedural complications after penile girth injections seem to be under-reported and unfortunately can result in severe deformity and dysfunction of the penis.

1 January 2021 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
DKDane E. Klett
Dane E. Klett
BBBryce Baird
Bryce Baird
CBColleen T. Ball
Colleen T. Ball
CDChandler D. Dora
Chandler D. Dora
Klett DE, et al. Investig Clin Urol. 2021 Oct;62:e72. https://doi.org/10.4111/icu.20210182

26 February 2022 in The Journal of Sexual Medicine
Verified
Journal Article
Closed access
BBBryce Baird
Bryce Baird
EWEthan Wajswol
Ethan Wajswol
CEChristian Ericson
Christian Ericson
AAAugustus Anderson
Augustus Anderson
GBGregory Broderick
Gregory Broderick
Background: Intracavernosal injections (ICI) are a well-established treatment option for men with erectile dysfunction (ED); however, the anticipation of pain with injection remains a significant barrier to the use of ICI.Aim: To evaluate the patient-anticipated degree of pain versus the experienced degree of pain pre- and post-ICI in men undergoing their first injection with an erectile agent.Methods: We studied 51 patients who underwent their first ICI in our men’s health clinic. Anticipated needle-associated pain was judged with a pre-injection score, and pain experienced during the injection was judged with a post-injection score. All patients graded their pre- and post-ICI pain using a standard 10-point scale (0–10).Outcomes: Pre- and post-ICI pain was defined with the visual analogue scale (0–10) in men undergoing their first penile injection.Results: Medians and interquartile ranges (IQRs) of the patients’ age [65 years (54.5–68.0)], pre-injection pain [5 (4–7)], and post-injection pain [1 (1–2)] were recorded. Most men in the study had erectile dysfunction (68.6%) and/or Peyronie’s Disease (64.7%). The average pre-injection prediction pain score was 5.45 ± 2.15; the average post-injection perceived pain score was 1.20 ± 0.73. Thus, there was an average discrepancy of over 4 points in predicted pain vs perceived pain. A paired t-test was performed which showed a statistically significant difference between pre- and post-injection scores (P < .05). A Wilcoxson Signed Rank Test showed statistical significance in the difference between pre- and post-injection pain scores (P < .05).Clinical Implications: ICI is a safe, effective treatment for patients with ED and is associated with significantly less pain than is anticipated by patients.Strengths & Limitations: This is the first report to describe the discrepancy between pre-ICI anticipated pain and post-ICI experienced pain. Limitations include an overall small sample size.Conclusion: Patients experience significantly less pain with ICI than they anticipate having. This represents an important factor to consider when counseling patients about available ED treatments.

10 July 2022 in Urology
Verified
Journal Article
Closed access
JHJames Hwang
James Hwang
BBBryce Baird
Bryce Baird
TTTiara Taylor
Tiara Taylor
SBShalmali Borkar
Shalmali Borkar
EBEmily Brennan
Emily Brennan
TLTimothy D. Lyon
Timothy D. Lyon

19 October 2022 in Urology Case Reports
Verified
Journal Article
Open access
JDJustin David
Justin David
BBBryce Baird
Bryce Baird
ANAziza Nassar
Aziza Nassar
LGLaura Geldmaker
Laura Geldmaker
GBGregory A. Broderick
Gregory A. Broderick
BK virus cystitis is known to occur following hematopoietic stem cell transplant (HSCT), but few cases exist in the literature following lung transplant. Because of the rarity of this presentation, patients may have missed diagnoses and prescribed ineffective treatments. We present our case of an atypical presentation of BK virus cystitis appearing as bladder carcinoma in situ in a lung transplant patient.